Patients with multiple myeloma over a large catchment of 2.5 million square kilometres: a Western Australia retrospective survival review
- PMID: 32656980
- DOI: 10.1111/imj.14905
Patients with multiple myeloma over a large catchment of 2.5 million square kilometres: a Western Australia retrospective survival review
Abstract
Multiple myeloma is an incurable malignancy of plasma cells. We retrospectively reviewed the survival outcomes of patients with multiple myeloma in Western Australia (WA) public hospitals over a 10-year period. We did not detect a difference in survival between patients residing the metropolitan Perth and regional areas, despite a paucity of haematology services in regional WA due to low population density in a large geographic area. Patients with R-ISS Stage 3 had the poorest survival in our cohort with median survival of 24 months.
Keywords: Western Australia; multiple myeloma; rural health; survival outcome.
© 2020 Royal Australasian College of Physicians.
References
-
- Australian Institute of Health and Welfare. Cancer in Australia 2017. Cancer Series No. 101. Cat. No. CAN 100. Canberra: AIHW; 2017.
-
- Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15: e538-48.
-
- Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L et al. Revised international staging system for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol 2015; 33: 2863-9.
-
- Tervonen HE, Aranda S, Roder D, You H, Walton R, Morrell S et al. Cancer survival disparities worsening by socio-economic disadvantage over the last 3 decades in new South Wales, Australia. BMC Public Health 2017; 17: 691.
-
- Wilkinson D, Cameron K. Cancer and cancer risk in South Australia: what evidence for a rural-urban health differential? Aust J Rural Health 2004; 12: 61-6.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical